These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23603920)

  • 1. Global advances in prostate cancer diagnosis and therapy.
    Walia G; Sun Y; Soule HR
    Asian J Androl; 2013 May; 15(3):299-300. PubMed ID: 23603920
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in prostate cancer research.
    Languino LR
    J Cell Biochem; 2004 Jan; 91(1):1-2. PubMed ID: 14689575
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molecular diagnosis and gene therapy for prostate cancer].
    Nasu Y; Kumon H
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():28-32. PubMed ID: 12599540
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modern methods of prostate cancer diagnostics].
    Bryzgunova OE; Vlasov VV; Laktiononv PP
    Biomed Khim; 2007; 53(2):128-39. PubMed ID: 17639714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best of 2022 in prostate cancer and prostatic diseases.
    De Nunzio C; Lombardo R
    Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):5-7. PubMed ID: 36739329
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advances in the diagnosis and therapy of prostate cancer. International symposium, 13 March 1993, Vienna].
    Urologe A; 1993 Jul; 32(4 Suppl):1-8. PubMed ID: 7483149
    [No Abstract]   [Full Text] [Related]  

  • 7. The genetic classification of prostate cancer: what's on the horizon?
    Ross-Adams H; Lamb AD
    Future Oncol; 2016 Mar; 12(6):729-33. PubMed ID: 26859444
    [No Abstract]   [Full Text] [Related]  

  • 8. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Diagnosis and Treatment of Early Stage Prostate Cancer. Symposium proceedings. Quebec City, Quebec, May 29-30, 1993.
    Clin Invest Med; 1993 Dec; 16(6):407-538. PubMed ID: 7912173
    [No Abstract]   [Full Text] [Related]  

  • 10. [Updated application of prostate-specific membrane antigen to the diagnosis and treatment of prostate cancer].
    Tang QL; Yao MY
    Zhonghua Nan Ke Xue; 2008 Jan; 14(1):79-82. PubMed ID: 18297820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostate specific antigen (PSA) in the diagnosis and treatment of prostate carcinoma: advances and controversies].
    Popov I; Radosevic-Jelic Lj
    Srp Arh Celok Lek; 2001; 129(5-6):159-62. PubMed ID: 11797466
    [No Abstract]   [Full Text] [Related]  

  • 12. Practice guidelines for prostate cancer.
    Ahlering T; Parker R; Kumar S; Taylor C; Gilden R; Figlin RA
    Cancer J Sci Am; 1996; 2(3A Suppl):S77-86. PubMed ID: 9166527
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prostate cancer center: a multidisciplinary approach to accurately manage patients with prostate cancer].
    Tawadros T; Burruni R; Herrera F; Codeluppi C; Zurkinden C; Meuwly JY; Lhermitte B; Berthold D
    Rev Med Suisse; 2013 Dec; 9(409):2270-2, 2274. PubMed ID: 24416882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Localized Prostate Cancer Management.
    Samadi DB; Feuerstein MA; Jazayeri SB; Kaplan SA; Farahat Y
    Biomed Res Int; 2018; 2018():2807813. PubMed ID: 29511674
    [No Abstract]   [Full Text] [Related]  

  • 15. [Development of promising biomarkers for prostate cancer].
    Yoneyama T; Ohyama C
    Nihon Rinsho; 2016 May; 74 Suppl 3():191-5. PubMed ID: 27344727
    [No Abstract]   [Full Text] [Related]  

  • 16. Precision medicine for prostate cancer.
    Galazi M; Rodriguez-Vida A; Ng T; Mason M; Chowdhury S
    Expert Rev Anticancer Ther; 2014 Nov; 14(11):1305-15. PubMed ID: 25354871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer of the prostate: recent findings and the immediate future].
    Ravaud A; Bay JO
    Bull Cancer; 2007 Jul; 94(7 Suppl):F3-4. PubMed ID: 17845987
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in prostate cancer research. Part II.
    Languino LR
    J Cell Biochem; 2004 Feb; 91(3):431-2. PubMed ID: 15952248
    [No Abstract]   [Full Text] [Related]  

  • 19. Retinoic acid receptor beta2 hypermethylation: implications for prostate cancer detection, prevention, and therapy.
    Lotan R; Lotan Y
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3935-6. PubMed ID: 15217922
    [No Abstract]   [Full Text] [Related]  

  • 20. Focal therapy for prostate cancer: recent advances and future directions.
    Wang A; O'Connor LP; Yerram NK; Nandanan N; Ahdoot M; Lebastchi AH; Gurram S; Chalfin H; Pinto PA
    Clin Adv Hematol Oncol; 2020 Feb; 18(2):116-125. PubMed ID: 32558805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.